Announced Thu, 13 Aug, 2026 · 19:28 IST
Company confirms SEBI disclosure rule on share issues not applicable for June quarter
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+0.0%1-day move
₹0.47
prior close
₹0.46
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+2.2+2.2+2.2+2.2+0.0+0.0-2.1+0.0+0.0+0.0+0.0+0.0——
Up moveDown movePending
AI summary
Johnson Pharmacare filed an undertaking with BSE confirming SEBI Regulation 32 is not applicable for the quarter ended June 30, 2026. This rule requires listed companies to report on use of proceeds from share issues. The company states it did not raise capital through public, rights, or preferential issues in the quarter. Signed by Additional Director Nand Kishor Ray.
Likely market impact
Routine compliance filing. No share issuance happened in the quarter, so no material business or stock impact.